Work

Supplementary Figure S6 from Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Year: 2023
Type: supplementary-materials
Abstract: Progression-free survival (left) and overall survival (right) according to TP53 co-mutation status in A) overall cohort, B) cohort A, and C) cohort B.
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4383535655
Cites:
Cited by:
Related to: 10